Michiko Ichii

1.1k total citations
52 papers, 776 citations indexed

About

Michiko Ichii is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Michiko Ichii has authored 52 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 25 papers in Hematology and 17 papers in Molecular Biology. Recurrent topics in Michiko Ichii's work include Hematopoietic Stem Cell Transplantation (15 papers), Immune Cell Function and Interaction (11 papers) and T-cell and B-cell Immunology (9 papers). Michiko Ichii is often cited by papers focused on Hematopoietic Stem Cell Transplantation (15 papers), Immune Cell Function and Interaction (11 papers) and T-cell and B-cell Immunology (9 papers). Michiko Ichii collaborates with scholars based in Japan, United States and Netherlands. Michiko Ichii's co-authors include Paul W. Kincade, Yuzuru Kanakura, Kenji Oritani, Frank J. T. Staal, Tiago C. Luís, Martijn H. Brugman, Takafumi Yokota, Mark Barton Frank, Renato V. Iozzo and Karla P. Garrett and has published in prestigious journals such as Nucleic Acids Research, Blood and The Journal of Immunology.

In The Last Decade

Michiko Ichii

47 papers receiving 768 citations

Peers

Michiko Ichii
Karen-Sue Carlson United States
Heather A. O’Leary United States
Xavier Langa Switzerland
Mary Georger United States
Serena De Vita United States
Timothy M. Chlon United States
Puneet Agarwal United States
Karen-Sue Carlson United States
Michiko Ichii
Citations per year, relative to Michiko Ichii Michiko Ichii (= 1×) peers Karen-Sue Carlson

Countries citing papers authored by Michiko Ichii

Since Specialization
Citations

This map shows the geographic impact of Michiko Ichii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michiko Ichii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michiko Ichii more than expected).

Fields of papers citing papers by Michiko Ichii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michiko Ichii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michiko Ichii. The network helps show where Michiko Ichii may publish in the future.

Co-authorship network of co-authors of Michiko Ichii

This figure shows the co-authorship network connecting the top 25 collaborators of Michiko Ichii. A scholar is included among the top collaborators of Michiko Ichii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michiko Ichii. Michiko Ichii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ose, Toyoyuki, Yuichi Kitai, Ryuta Muromoto, et al.. (2023). STAP-2–Derived Peptide Suppresses TCR-Mediated Signals to Initiate Immune Responses. The Journal of Immunology. 211(5). 755–766. 2 indexed citations
2.
Kashiwakura, Jun‐ichi, Yuichi Sekine, Yuichi Kitai, et al.. (2022). STAP-2 Is a Novel Positive Regulator of TCR-Proximal Signals. The Journal of Immunology. 209(1). 57–68. 8 indexed citations
3.
Tanimura, Akira, Takafumi Yokota, Sachiko Ezoe, et al.. (2022). Impaired B cell terminal differentiation in B cell-specific knockout mice of cell death-defying factor anamorsin. Biochemical and Biophysical Research Communications. 603. 1–6.
4.
Kitai, Yuichi, Jun‐ichi Kashiwakura, Ryuta Muromoto, et al.. (2021). Positive interactions between STAP-1 and BCR-ABL influence chronic myeloid leukemia cell proliferation and survival. Biochemical and Biophysical Research Communications. 556. 185–191. 8 indexed citations
5.
Saito, Hideaki, Hiroaki Miyoshi, Hirohiko Shibayama, et al.. (2021). High numbers of programmed cell death-1-positive tumor infiltrating lymphocytes correlate with early onset of post-transplant lymphoproliferative disorder. International Journal of Hematology. 114(1). 53–64.
6.
Ichii, Michiko, et al.. (2021). Signal-transducing adaptor protein-1 and protein-2 in hematopoiesis and diseases. Experimental Hematology. 105. 10–17. 5 indexed citations
7.
Ezoe, Sachiko, Jiro Fujita, Daisuke Okuzaki, et al.. (2020). Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function. Leukemia. 35(1). 107–118. 25 indexed citations
8.
Ichii, Michiko, Kenji Oritani, Hirohiko Shibayama, et al.. (2020). Signal-transducing adapter protein-1 is required for maintenance of leukemic stem cells in CML. Oncogene. 39(34). 5601–5615. 13 indexed citations
9.
Ichii, Michiko, Kenji Oritani, Hideaki Saito, et al.. (2020). Signal-transducing adaptor protein-2 delays recovery of B lineage lymphocytes during hematopoietic stress. Haematologica. 106(2). 424–436. 7 indexed citations
10.
Yokota, Takafumi, Daisuke Okuzaki, Yoshihiro Uno, et al.. (2019). Endothelial Cell-Selective Adhesion Molecule Contributes to the Development of Definitive Hematopoiesis in the Fetal Liver. Stem Cell Reports. 13(6). 992–1005. 21 indexed citations
11.
Kobayashi, Eiji, et al.. (2019). A successful intraoperative diagnosis of coexisting lymphoma and endometrial cancer. World Journal of Surgical Oncology. 17(1). 166–166. 3 indexed citations
12.
Koh, Shizuka, et al.. (2019). Transient Cornea Verticillata of Unknown Etiology. Cornea. 1–1. 1 indexed citations
13.
Doi, Yukiko, Takafumi Yokota, Yusuke Satoh, et al.. (2018). Variable SATB1 Levels Regulate Hematopoietic Stem Cell Heterogeneity with Distinct Lineage Fate. Cell Reports. 23(11). 3223–3235. 26 indexed citations
14.
Ishibashi, Tomohiko, Takafumi Yokota, Hirokazu Tanaka, et al.. (2016). ESAM is a novel human hematopoietic stem cell marker associated with a subset of human leukemias. Experimental Hematology. 44(4). 269–281.e1. 22 indexed citations
15.
Ichii, Michiko, Tetsuo Maeda, Takafumi Yokota, et al.. (2015). Identification of osteoblast stimulating factor 5 as a negative regulator in the B-lymphopoietic niche. Experimental Hematology. 43(11). 963–973.e4. 4 indexed citations
16.
Yokota, Takafumi, Takao Sudo, Tomohiko Ishibashi, et al.. (2013). Complementary regulation of early B-lymphoid differentiation by genetic and epigenetic mechanisms. International Journal of Hematology. 98(4). 382–389. 8 indexed citations
17.
Ichii, Michiko, Kenji Oritani, Takafumi Yokota, et al.. (2010). The Density of CD10 Corresponds to Commitment and Progression in the Human B Lymphoid Lineage. PLoS ONE. 5(9). e12954–e12954. 31 indexed citations
18.
Ichii, Michiko, Kenji Oritani, Takafumi Yokota, et al.. (2008). Regulation of human B lymphopoiesis by the transforming growth factor-β superfamily in a newly established coculture system using human mesenchymal stem cells as a supportive microenvironment. Experimental Hematology. 36(5). 587–597. 24 indexed citations
19.
Ujiie, Hidetoshi, Kenji Oritani, Hisashi Kato, et al.. (2006). Identification of amino-terminal region of adiponectin as a physiologically functional domain. Journal of Cellular Biochemistry. 98(1). 194–207. 17 indexed citations
20.
Ishida, Naoko, Kenji Oritani, Masamichi Shiraga, et al.. (2005). Differential effects of a novel IFN-ζ/limitin and IFN-α on signals for Daxx induction and Crk phosphorylation that couple with growth control of megakaryocytes. Experimental Hematology. 33(4). 495–503. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026